1. Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma 
Yair Lotan, M.D., Paul OʼSullivan, Ph.D., Jay D. Raman, M.D., Sharokh F. Shariat, M.D., Laimonis Kavalieris, Ph.D., Chris Frampton, Ph.D., Parry Guilford, Ph.D., Carthika Luxmanan, Ph.D., James Suttie, Ph.D., Henry Crist, M.D., Douglas Scherr, M.D., Scott Asroff, M.D., Evan Goldfischer, M.D., M.B.A., Jeffrey Thill, M.D., David Darling, M.B.A. 
Urologic Oncology: Seminars and Original Investigations 
Volume 35, Issue 8, Pages 531.e e22 (August 2017)
DOI: /j.urolonc
Copyright © 2017 The Authors Terms and Conditions

2. Fig. 1
Standards for Reporting of Diagnostic Accuracy (STARD) diagram for patient recruitment and enrollment.
Urologic Oncology: Seminars and Original Investigations  , 531.e e22DOI: ( /j.urolonc )
Copyright © 2017 The Authors Terms and Conditions

3. Fig. 2
Receiver operating curves for the Cxbladder Monitor test and comparator urine tests. Dashed lines represent the performance characteristics of the Cxbladder Monitor test.
Urologic Oncology: Seminars and Original Investigations  , 531.e e22DOI: ( /j.urolonc )
Copyright © 2017 The Authors Terms and Conditions